Karen Dawes

Founder at Knowledgeable Decisions LLC

Karen Dawes

Karen Dawes

Founder at Knowledgeable Decisions LLC

Career Highlights

Knowledgeable Decisions LLC
The ProPharmex Group

RelSci Relationships


Number of Boards






RelSci Relationships are individuals Karen Dawes likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer & Director at PDL BioPharma, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at REPLIGEN Corp.

Relationship likelihood: Strong

Chief Executive Officer at Repertoire Immune Medicines

Relationship likelihood: Strong

Former Chief Executive Officer at Protein Design Labs, Inc.

Relationship likelihood: Strong

Founding Member at International Biomedicine Management Partners AG

Relationship likelihood: Strong

Former Director at National Cancer Institute

Relationship likelihood: Strong

Director at Theron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Professional at George M. Gould LLC

Relationship likelihood: Strong

Vice President of Service at Solutionz Videoconferencing, Inc.

Relationship likelihood: Strong

Paths to Karen Dawes
Potential Connections via
Relationship Science
Karen Dawes
Founder at Knowledgeable Decisions LLC
M.A. in English & Communications

Since 1899, Simmons has offered a pioneering liberal arts education for undergraduate women integrated with professional work experience. Today, Simmons also encompasses the many benefits of a small university, including renowned coeducational graduate programs in health sciences, education, liberal arts, library and information science, management, and social work. They also offer an MBA program designed specifically for women.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

MBA with Concentration in Marketing & Corporate Strategy

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
2003 - Current
Division Head, US Pharmaceuticals Division
1998 - 2003

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Chief Commercial Officer
1994 - 1998

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Boards & Committees

Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA.

2003 - 2006

Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.

2003 - 2008

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Political Donations

Former Senator from Michigan

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karen Dawes. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karen Dawes's profile does not indicate a business or promotional relationship of any kind between RelSci and Karen Dawes.